HK1037675A1 - Human orphan g protein-coupled receptor rup3. - Google Patents
Human orphan g protein-coupled receptor rup3.Info
- Publication number
- HK1037675A1 HK1037675A1 HK01108607A HK01108607A HK1037675A1 HK 1037675 A1 HK1037675 A1 HK 1037675A1 HK 01108607 A HK01108607 A HK 01108607A HK 01108607 A HK01108607 A HK 01108607A HK 1037675 A1 HK1037675 A1 HK 1037675A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- protein
- rup3
- coupled receptor
- human orphan
- orphan
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (24)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10921398P | 1998-11-20 | 1998-11-20 | |
US12041699P | 1999-02-16 | 1999-02-16 | |
US12185299P | 1999-02-26 | 1999-02-26 | |
US12394699P | 1999-03-12 | 1999-03-12 | |
US12394999P | 1999-03-12 | 1999-03-12 | |
US13656799P | 1999-05-28 | 1999-05-28 | |
US13713199P | 1999-05-28 | 1999-05-28 | |
US13643699P | 1999-05-28 | 1999-05-28 | |
US13643799P | 1999-05-28 | 1999-05-28 | |
US13712799P | 1999-05-28 | 1999-05-28 | |
US13643999P | 1999-05-28 | 1999-05-28 | |
US14144899P | 1999-06-29 | 1999-06-29 | |
US15655599P | 1999-09-29 | 1999-09-29 | |
US15665399P | 1999-09-29 | 1999-09-29 | |
US15663399P | 1999-09-29 | 1999-09-29 | |
US15663499P | 1999-09-29 | 1999-09-29 | |
US15728199P | 1999-10-01 | 1999-10-01 | |
US15728099P | 1999-10-01 | 1999-10-01 | |
US15728299P | 1999-10-01 | 1999-10-01 | |
US15729399P | 1999-10-01 | 1999-10-01 | |
US15729499P | 1999-10-01 | 1999-10-01 | |
US41704499A | 1999-10-12 | 1999-10-12 | |
US41676099A | 1999-10-12 | 1999-10-12 | |
PCT/US1999/023687 WO2000031258A2 (en) | 1998-11-20 | 1999-10-13 | Human orphan g protein-coupled receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1037675A1 true HK1037675A1 (en) | 2002-02-15 |
Family
ID=27586698
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01108607A HK1037675A1 (en) | 1998-11-20 | 2001-12-07 | Human orphan g protein-coupled receptor rup3. |
HK07112367A HK1103763A1 (en) | 1998-11-20 | 2005-12-02 | Human orphan g protein-coupled receptor rup3 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07112367A HK1103763A1 (en) | 1998-11-20 | 2005-12-02 | Human orphan g protein-coupled receptor rup3 |
Country Status (13)
Country | Link |
---|---|
EP (8) | EP2295574A1 (de) |
JP (5) | JP2003534767A (de) |
KR (5) | KR100926208B1 (de) |
AT (3) | ATE366815T1 (de) |
AU (2) | AU770056B2 (de) |
CA (2) | CA2645717A1 (de) |
DK (3) | DK1849866T3 (de) |
ES (3) | ES2289610T3 (de) |
HK (2) | HK1037675A1 (de) |
IL (2) | IL142538A0 (de) |
NZ (3) | NZ527622A (de) |
PT (3) | PT1584683E (de) |
WO (1) | WO2000031258A2 (de) |
Families Citing this family (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69938015T2 (de) | 1998-03-12 | 2009-01-15 | Astellas Pharma Inc. | Neue G Protein-gekoppelte Rezeptorproteine |
US6071722A (en) * | 1998-04-24 | 2000-06-06 | Smithkline Beecham Corporation | Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1) |
JP2002512780A (ja) * | 1998-04-24 | 2002-05-08 | スミスクライン ビーチャム コーポレーション | 新規7tm受容体axor−2のクローニング |
EP1155031A4 (de) * | 1998-11-03 | 2002-11-27 | Smithkline Beecham Corp | Axor14, ein g-protein gekoppelter rezeptor |
US7816492B2 (en) | 1998-11-20 | 2010-10-19 | Arena Pharmaceuticals, Inc. | Human G protein-coupled receptors |
USRE42190E1 (en) | 1998-11-20 | 2011-03-01 | Arena Pharmaceuticals, Inc. | Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors |
US20030017528A1 (en) | 1998-11-20 | 2003-01-23 | Ruoping Chen | Human orphan G protein-coupled receptors |
US6221660B1 (en) | 1999-02-22 | 2001-04-24 | Synaptic Pharmaceutical Corporation | DNA encoding SNORF25 receptor |
EP1157038A4 (de) * | 1999-02-26 | 2005-01-19 | Smithkline Beecham Corp | KLONIERUNG EINES P2Y-äHNLICHEN 7TM-REZEPTORS (AXOR17) |
US6620615B1 (en) | 1999-04-23 | 2003-09-16 | Curagen Corporation | G-protein coupled receptor—encoding nucleic acids |
WO2000078809A1 (en) * | 1999-06-21 | 2000-12-28 | Smithkline Beecham Corporation | Axor16, a g protein coupled receptor |
JP2003504054A (ja) * | 1999-07-13 | 2003-02-04 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | G−タンパク質共役型受容体およびそのdna配列 |
CA2381437A1 (en) * | 1999-07-30 | 2001-02-08 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | G-protein coupled receptor and dna sequences thereof |
CA2382889A1 (en) * | 1999-08-27 | 2001-03-08 | Takuya Watanabe | Novel g protein-coupled receptor protein and dna thereof |
US6998255B1 (en) | 1999-09-24 | 2006-02-14 | Solvay Pharmaceuticals B.V. | Human G-protein coupled receptor |
GB9923177D0 (en) * | 1999-09-30 | 1999-12-01 | Pfizer Ltd | Novel polypeptide |
US6204017B1 (en) | 1999-10-07 | 2001-03-20 | Schering Corporation | Polynucleotide encoding a histamine receptor |
GB9923890D0 (en) * | 1999-10-08 | 1999-12-08 | Pfizer Ltd | Novel polypeptide |
GB9923893D0 (en) * | 1999-10-08 | 1999-12-08 | Pfizer Ltd | Novel polypeptide |
GB9924956D0 (en) * | 1999-10-21 | 1999-12-22 | Pfizer Ltd | Novel polypeptide |
GB9924960D0 (en) * | 1999-10-21 | 1999-12-22 | Pfizer Ltd | Novel polypeptide |
CA2386509A1 (en) * | 1999-10-27 | 2001-05-03 | Pharmacia & Upjohn Company | G protein-coupled receptors expressed in human brain |
ES2291177T3 (es) * | 1999-10-29 | 2008-03-01 | Pfizer Inc. | Polipeptido de tipo receptor acoplado a proteina g. |
WO2001032864A2 (en) * | 1999-11-03 | 2001-05-10 | Merck Patent Gmbh | Gpcr-kd5 polypeptides and dna sequences thereof |
US6461836B1 (en) * | 1999-11-05 | 2002-10-08 | Smithkline Beecham Corporation | Molecular cloning of a 7TM receptor (AxOR34) and screening methods thereof |
CA2388865A1 (en) * | 1999-11-16 | 2001-05-25 | Pharmacia & Upjohn Company | Novel g protein-coupled receptors |
US7029857B1 (en) | 1999-12-17 | 2006-04-18 | H. Lundbeck A/S | Processes for obtaining compounds employing SNORF72 receptors |
AU2398501A (en) * | 1999-12-20 | 2001-07-03 | Banyu Pharmaceutical Co., Ltd. | Novel guanosine triphosphate-binding protein-coupled receptor protein, bg26 |
WO2001046454A1 (en) | 1999-12-23 | 2001-06-28 | Cor Therapeutics, Inc. | P2y12 receptor |
AU2230401A (en) * | 1999-12-28 | 2001-07-09 | Helix Research Institute | Novel guanosine triphosphate-binding protein-coupled receptors, genes thereof and production and use of the same |
GB0001700D0 (en) * | 2000-01-25 | 2000-03-15 | Glaxo Group Ltd | Novel protein |
US7138249B2 (en) | 2000-02-04 | 2006-11-21 | Takeda Pharmaceutical Company Limited | Screening method |
ES2283403T3 (es) * | 2000-03-14 | 2007-11-01 | Bayer Healthcare Ag | Regulacion de la proteina similar al receptor de la lipoxina a4 humana. |
US20040091863A1 (en) * | 2000-03-17 | 2004-05-13 | Shyam Ramakrishnan | Regulation of human leukotriene b4-like g protein-coupled receptor |
EP1270589A4 (de) * | 2000-03-21 | 2004-09-29 | Yamanouchi Pharma Co Ltd | Neuer leukotrienb4 rezeptor |
US20030087287A1 (en) * | 2000-03-28 | 2003-05-08 | Masanori Miwa | Novel g-protein-coupled receptor protein and dna thereof |
AU4467301A (en) * | 2000-03-31 | 2001-10-08 | Helix Research Institute | Novel guanosine triphosphate-binding protein-coupled receptor gprv53, gene thereof and production and use of the same |
WO2001077326A1 (fr) * | 2000-04-12 | 2001-10-18 | Takeda Chemical Industries, Ltd. | Proteine receptrice couplee a la proteine g et son adn |
EP1178110A1 (de) * | 2000-08-01 | 2002-02-06 | Aventis Pharma Deutschland GmbH | EDG8 Rezeptor für Sphingosine 1-Phosphate , dessen Herstellung und Anwendung |
PT1287133E (pt) * | 2000-05-18 | 2007-03-30 | Bayer Healthcare Ag | Regulação do receptor acoplado à proteína g tipo dopamina humano |
WO2002000719A2 (en) * | 2000-06-23 | 2002-01-03 | Tularik Inc. | Human and mouse g-protein couipled receptors |
WO2002000725A2 (en) * | 2000-06-26 | 2002-01-03 | Akzo Nobel N.V. | G-protein coupled receptor org10 |
AU2001281933A1 (en) * | 2000-06-30 | 2002-01-14 | Ingenium Pharmaceuticals Ag | Human g protein-coupled receptor igpcr17, and uses therof |
AU2001271838A1 (en) | 2000-07-06 | 2002-01-21 | Bayer Corporation | Human neuropeptide y-like g protein-coupled receptor |
AU2001279232A1 (en) * | 2000-08-09 | 2002-02-18 | Millennium Pharmaceuticals, Inc. | Methods for using 14266, a human g protein-coupled receptor |
US6790608B2 (en) * | 2000-09-20 | 2004-09-14 | The Regents Of The University Of California | Methods of identifying and ADP-glucose receptor ligand, agonist or antagonist |
EP1331228B1 (de) | 2000-11-01 | 2007-03-21 | Astellas Pharma Inc. | VERFAHREN ZUM SCREENEN EINES PLäTTCHENHEMMERS |
CA2426037A1 (en) * | 2000-11-07 | 2002-05-16 | Paradigm Therapeutics Limited | A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
CN1549858A (zh) * | 2000-11-27 | 2004-11-24 | 阿伦纳药品公司 | 内源和非内源型人g蛋白偶联受体 |
DE60125227T2 (de) | 2000-12-01 | 2007-09-20 | Astellas Pharma Inc. | Verfahren zum screening von diabetes-heilverfahren |
WO2002057311A2 (en) | 2000-12-22 | 2002-07-25 | University Of South Florida | Sphingosine 1-phosphate receptor gene, sppr |
WO2002052047A2 (en) * | 2000-12-22 | 2002-07-04 | Mergen Ltd. | Methods for identifying g-protein coupled receptors associated with diseases |
GB0100782D0 (en) * | 2001-01-11 | 2001-02-21 | Glaxo Group Ltd | Assay |
JPWO2002088355A1 (ja) * | 2001-04-25 | 2004-08-19 | 藤沢薬品工業株式会社 | 新規なグアノシン三リン酸結合タンパク質共役型の受容体place6002312およびその遺伝子、並びにそれらの製造および用途 |
US20030096299A1 (en) | 2001-07-09 | 2003-05-22 | Valerie Wittamer | Natural ligand of G protein coupled receptor ChemR23 and uses thereof |
US7419658B2 (en) | 2001-07-09 | 2008-09-02 | Euroscreen S.A. | Isolated ligand of ChemerinR |
US7858755B2 (en) | 2001-07-09 | 2010-12-28 | Euroscreen S.A. | Monoclonal antibodies that bind Chemerin polypeptide |
US6946244B2 (en) | 2001-08-07 | 2005-09-20 | Euroscreen, S.A. | Methods of identifying a ligand, an agonist, and an antagonist of G protein coupled receptor GPR86 (P2Y13) |
CA2481508A1 (en) | 2002-04-12 | 2003-10-23 | Schering Corporation | G-protein coupled receptor ligands and methods |
AU2003261874A1 (en) * | 2002-09-02 | 2004-03-29 | Takeda Pharmaceutical Company Limited | Adrenocortical hormone secretion controller |
WO2004033687A1 (ja) * | 2002-10-11 | 2004-04-22 | Yamanouchi Pharmaceutical Co., Ltd. | 腎不全治療薬をスクリーニングする方法 |
US7056685B1 (en) | 2002-11-05 | 2006-06-06 | Amgen Inc. | Receptor ligands and methods of modulating receptors |
WO2004058149A2 (en) | 2002-12-20 | 2004-07-15 | Merck & Co., Inc. | 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles |
EP1599468B1 (de) | 2003-01-14 | 2007-10-03 | Arena Pharmaceuticals, Inc. | 1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie |
US7083933B1 (en) | 2003-05-09 | 2006-08-01 | Prosidion Limited | Methods for identification of modulators of OSGPR116 activity |
EP1648488A4 (de) * | 2003-06-27 | 2007-01-24 | Tanox Inc | In menschlichen mastzellen exprimiertes membranprotein |
US7524638B1 (en) | 2003-06-27 | 2009-04-28 | Osi Pharmaceuticals, Inc. | Methods for identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease |
DOP2006000008A (es) * | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
GB0508990D0 (en) * | 2005-05-03 | 2005-06-08 | Novartis Ag | Organic compounds |
EP1971862B1 (de) | 2006-04-11 | 2010-11-10 | Arena Pharmaceuticals, Inc. | Verfahren zur verwendung des gpr119-rezeptors zur identifizierung von verbindungen zur erhöhung der knochenmasse bei einer person |
US7638541B2 (en) | 2006-12-28 | 2009-12-29 | Metabolex Inc. | 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
AU2008279447A1 (en) | 2007-07-19 | 2009-01-29 | Metabolex, Inc. | N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders |
ES2499018T3 (es) | 2007-09-20 | 2014-09-26 | Irm Llc | Compuestos y composiciones como moduladores de la actividad de GPR119 |
EP2146210A1 (de) | 2008-04-07 | 2010-01-20 | Arena Pharmaceuticals, Inc. | Verfahren zur Verwendung eines AG-Protein-gekoppelten Rezeptors zur Identifikation von Peptid-YY (PPY)-Sekretagogen sowie Verbindungen zur Behandlung durch PYY modulierter Leiden |
AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
ES2497566T3 (es) | 2009-10-01 | 2014-09-23 | Cymabay Therapeutics, Inc. | Sales de tetrazol-1-il-fenoximetil-tiazol-2-il-piperidinil-pirimidina sustituida |
US8791100B2 (en) | 2010-02-02 | 2014-07-29 | Novartis Ag | Aryl benzylamine compounds |
EP2556056A1 (de) | 2010-04-06 | 2013-02-13 | Arena Pharmaceuticals, Inc. | Modulatoren des gpr119-rezeptors und behandlung von damit assoziierten erkrankungen |
EP2585048B1 (de) | 2010-06-23 | 2018-04-11 | CymaBay Therapeutics, Inc. | Zusammensetzungen von 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidin |
KR101871011B1 (ko) | 2010-09-22 | 2018-06-25 | 아레나 파마슈티칼스, 인크. | Gpr119 수용체의 조절제 및 그와 관련된 장애의 치료 |
WO2012135570A1 (en) | 2011-04-01 | 2012-10-04 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145361A1 (en) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145603A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145604A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
MX2017008925A (es) | 2015-01-06 | 2017-10-11 | Arena Pharm Inc | Metodos de condiciones de tratamiento relacionadas con el receptor s1p1. |
PT3310760T (pt) | 2015-06-22 | 2022-11-10 | Arena Pharm Inc | Sal cristalino de l-arginina de ácido (r)-2-(7-(4-ciclopentil-3-(trifluorometil)benziloxi)-1,2,3,4-tetrahidrociclo-penta[b]indol-3-il)acético para utilização em distúrbios associados a recetores de s1p1 |
CN109862896A (zh) | 2016-08-03 | 2019-06-07 | 西玛贝医药公司 | 用于治疗炎症性胃肠疾病或胃肠病症的氧亚甲基芳基化合物 |
JP2020524181A (ja) | 2017-06-19 | 2020-08-13 | アリーナ ファーマシューティカルズ, インコーポレイテッド | Nafldおよびnashの治療のための化合物および方法 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000500658A (ja) * | 1995-11-15 | 2000-01-25 | シーオーアール・セラピューティックス・インコーポレーテッド | 新規プリン受容体 |
JP2000505644A (ja) * | 1996-01-11 | 2000-05-16 | ヒューマン ジノーム サイエンシーズ,インコーポレイテッド | ヒトgタンパク質結合レセプター |
AU6017098A (en) * | 1997-01-21 | 1998-08-07 | Schering Corporation | Mammalian chemokines; receptors; reagents; uses |
US6221627B1 (en) * | 1997-02-24 | 2001-04-24 | Smithkline Beecham Corporation | cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
US5955303A (en) * | 1997-03-06 | 1999-09-21 | Incyte Pharmaceuticals, Inc. | Human chemokine receptor-like protein |
US6555339B1 (en) * | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
US6060272A (en) * | 1997-05-07 | 2000-05-09 | Human Genome Sciences, Inc. | Human G-protein coupled receptors |
EP0899332A3 (de) * | 1997-08-15 | 2000-07-05 | Smithkline Beecham Corporation | G-Protein gekoppelter Rezeptor HFIAO41 |
CA2239255A1 (en) * | 1997-10-23 | 1999-04-23 | Smithkline Beecham Corporation | Cdna clone hneaa81 that encodes a human 7-transmembrane receptor |
US5932445A (en) * | 1997-11-07 | 1999-08-03 | Incyte Pharmaceuticals, Inc. | Signal peptide-containing proteins |
US6252056B1 (en) * | 1997-11-11 | 2001-06-26 | Ono Pharmaceutical Co., Ltd. | Human lysophosphatidic acid receptor and use thereof |
US6207412B1 (en) * | 1997-11-13 | 2001-03-27 | The Regents Of The University Of California | Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells |
WO1999042484A1 (en) * | 1998-02-20 | 1999-08-26 | Smithkline Beecham Corporation | Fishboy, a g-protein coupled receptor |
DE69938015T2 (de) * | 1998-03-12 | 2009-01-15 | Astellas Pharma Inc. | Neue G Protein-gekoppelte Rezeptorproteine |
WO1999052945A2 (en) * | 1998-04-16 | 1999-10-21 | Millenium Pharmaceuticals, Inc. | NOVEL MOLECULES OF THE BGCKr-RELATED PROTEIN FAMILY AND USES THEREOF |
SE9801455D0 (sv) * | 1998-04-24 | 1998-04-24 | Astra Pharma Inc | New receptor |
JP2002512780A (ja) * | 1998-04-24 | 2002-05-08 | スミスクライン ビーチャム コーポレーション | 新規7tm受容体axor−2のクローニング |
US6071722A (en) * | 1998-04-24 | 2000-06-06 | Smithkline Beecham Corporation | Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1) |
CA2340334A1 (en) * | 1998-08-19 | 2000-03-02 | Millenium Pharmaceuticals, Inc. | 14274 receptor, a g-protein coupled receptor related to the edg receptor family |
CA2340457A1 (en) * | 1998-08-20 | 2000-03-02 | Millenium Pharmaceuticals, Inc. | 14400 receptor, a g-protein coupled receptor |
JP2002537757A (ja) * | 1998-08-24 | 2002-11-12 | アルファジーン・インコーポレイテッド | 分泌タンパク質及びそれらをコードするポリヌクレオチド |
AU5801099A (en) * | 1998-09-02 | 2000-03-21 | Millennium Pharmaceuticals, Inc. | 14926 receptor, a novel g-protein coupled receptor |
IL142153A0 (en) * | 1998-10-13 | 2002-03-10 | Arena Pharm Inc | Non-endogenous, constitutively activated human g protein-coupled receptors |
CA2344605A1 (en) * | 1998-10-16 | 2000-04-27 | Millennium Pharmaceuticals, Inc. | G-protein coupled receptors |
AU1242800A (en) * | 1998-11-04 | 2000-05-22 | Chiron Corporation | Isolated vshk-1 receptor polypeptides and methods of use thereof |
AU1712200A (en) * | 1998-11-06 | 2000-05-29 | Millennium Pharmaceuticals, Inc. | G-protein coupled receptors, homologous to ebv-induced gpcr 2 (ebi-2). methods to seek for ligands thereof |
US6221660B1 (en) * | 1999-02-22 | 2001-04-24 | Synaptic Pharmaceutical Corporation | DNA encoding SNORF25 receptor |
US6689866B1 (en) * | 1999-03-09 | 2004-02-10 | Curagen Corporation | Polynucleotides and proteins encoded thereby |
US6590938B1 (en) * | 1999-09-30 | 2003-07-08 | Conexant Systems, Inc. | DCT domain conversion of a higher definition signal to lower definition signal |
GB9923177D0 (en) * | 1999-09-30 | 1999-12-01 | Pfizer Ltd | Novel polypeptide |
-
1999
- 1999-10-13 ES ES05003040T patent/ES2289610T3/es not_active Expired - Lifetime
- 1999-10-13 WO PCT/US1999/023687 patent/WO2000031258A2/en active Application Filing
- 1999-10-13 EP EP10010658A patent/EP2295574A1/de not_active Withdrawn
- 1999-10-13 NZ NZ527622A patent/NZ527622A/en not_active IP Right Cessation
- 1999-10-13 KR KR1020077018185A patent/KR100926208B1/ko not_active IP Right Cessation
- 1999-10-13 KR KR1020087003578A patent/KR100963367B1/ko not_active IP Right Cessation
- 1999-10-13 ES ES07008841T patent/ES2308759T3/es not_active Expired - Lifetime
- 1999-10-13 EP EP99972682A patent/EP1133559B1/de not_active Expired - Lifetime
- 1999-10-13 DK DK07008841T patent/DK1849866T3/da active
- 1999-10-13 NZ NZ511087A patent/NZ511087A/en not_active IP Right Cessation
- 1999-10-13 DK DK05003040T patent/DK1584683T3/da active
- 1999-10-13 JP JP2000584067A patent/JP2003534767A/ja not_active Withdrawn
- 1999-10-13 PT PT05003040T patent/PT1584683E/pt unknown
- 1999-10-13 KR KR1020087003575A patent/KR100926209B1/ko not_active IP Right Cessation
- 1999-10-13 EP EP10008862A patent/EP2295572A1/de not_active Withdrawn
- 1999-10-13 KR KR1020087024998A patent/KR20080104062A/ko not_active Application Discontinuation
- 1999-10-13 IL IL14253899A patent/IL142538A0/xx unknown
- 1999-10-13 CA CA002645717A patent/CA2645717A1/en not_active Withdrawn
- 1999-10-13 AT AT05003040T patent/ATE366815T1/de active
- 1999-10-13 DK DK99972682T patent/DK1133559T3/da active
- 1999-10-13 AU AU37904/00A patent/AU770056B2/en not_active Ceased
- 1999-10-13 PT PT07008841T patent/PT1849866E/pt unknown
- 1999-10-13 AT AT99972682T patent/ATE301673T1/de active
- 1999-10-13 ES ES99972682T patent/ES2243095T3/es not_active Expired - Lifetime
- 1999-10-13 EP EP07001452A patent/EP1780280A1/de not_active Ceased
- 1999-10-13 EP EP05005946A patent/EP1580271A3/de not_active Ceased
- 1999-10-13 EP EP07008841A patent/EP1849866B1/de not_active Expired - Lifetime
- 1999-10-13 AT AT07008841T patent/ATE396400T1/de active
- 1999-10-13 CA CA002348377A patent/CA2348377C/en not_active Expired - Fee Related
- 1999-10-13 PT PT99972682T patent/PT1133559E/pt unknown
- 1999-10-13 EP EP05003040A patent/EP1584683B1/de not_active Expired - Lifetime
- 1999-10-13 EP EP10010303A patent/EP2295573A1/de not_active Withdrawn
- 1999-10-13 NZ NZ537625A patent/NZ537625A/en not_active IP Right Cessation
- 1999-10-13 KR KR1020017006279A patent/KR100765039B1/ko not_active IP Right Cessation
-
2001
- 2001-04-11 IL IL142538A patent/IL142538A/en not_active IP Right Cessation
- 2001-12-07 HK HK01108607A patent/HK1037675A1/xx not_active IP Right Cessation
-
2004
- 2004-04-28 JP JP2004132989A patent/JP2004267216A/ja not_active Withdrawn
- 2004-05-12 AU AU2004202147A patent/AU2004202147A1/en not_active Abandoned
-
2005
- 2005-12-02 HK HK07112367A patent/HK1103763A1/xx not_active IP Right Cessation
-
2007
- 2007-05-15 JP JP2007129923A patent/JP2007209352A/ja active Pending
-
2008
- 2008-02-14 JP JP2008033839A patent/JP2008133300A/ja active Pending
-
2009
- 2009-07-03 JP JP2009159339A patent/JP2009298791A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1103763A1 (en) | Human orphan g protein-coupled receptor rup3 | |
DE69709561D1 (de) | Östrogen-Rezeptor | |
HK1066018A1 (en) | Soluble t cell receptor. | |
AUPR833401A0 (en) | G protein-coupled receptor antagonists | |
DE69837606D1 (de) | Cystein-reiche rezeptoren-train | |
WO2002068600A3 (en) | Endogenous and non-endogenous versions of human g protein-coupled receptors | |
CY1107339T1 (el) | Mu-1, μελος της οικογενειας υποδοχεα κυτοκινης | |
EP1157097A4 (de) | DEM GALANINREZEPTOR äHNELNDER G-PROTEIN GEKOPPELTER REZEPTOR | |
WO2000052039A3 (en) | Lectomedin materials and methods | |
EP1142909A4 (de) | Guanosintriphosphat (gtp)-bindendes protein-gekoppelter rezeptor | |
EP0943685A3 (de) | Neuer G-Protein-gekoppelter Rezeptor aus menschlichem Gehirn | |
CY1107740T1 (el) | Ανθρωπινος ορφανος συζευγμενος σε g πρωτεϊνη υποδοχεας rup3 | |
AU2001238682A1 (en) | Human g protein-coupled receptors | |
AU2001257231A1 (en) | Novel g protein-coupled receptors | |
AU2001255472A1 (en) | Novel g protein-coupled receptor con-218 | |
WO2004069859A3 (en) | Restoring function to gonadotropin releasing hormone receptor mutants | |
AU5961201A (en) | Novel g protein-coupled receptors | |
AU2001259123A1 (en) | Novel g protein-coupled receptor | |
GB0107914D0 (en) | 7tm receptor hlwar77 | |
AU2001279232A1 (en) | Methods for using 14266, a human g protein-coupled receptor | |
AU2001241735A1 (en) | Novel g protein-coupled receptors | |
AU2002344325A1 (en) | Isolated human g protein-coupled receptor | |
AU2002335414A1 (en) | Novel g protein-coupled receptor | |
GB0107802D0 (en) | Novel g-protein coupled receptor | |
AU2001245514A1 (en) | Novel g protein-coupled receptors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20151013 |